Cellerant Therapeutics
Get Full AccessDescription
- Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant's lead product, CLT-008 is currently in two Phase 1 clinical trials in patients with hematological malignancies. The Company also has a Cancer Stem Cell (CSC) antibody discovery program focused on therapies for acute myeloid leukemia, multiple myeloma and myelodysplastic syndrome.
-
Headquarters:1561 Industrial Rd , San Carlos, California, United States
More -
Phone Number: +1 650-232-2122
-
Website: https://www.cellerant.com
-
Employees:26
-
Revenue:$10 - 50M
-
Legal Name:Cellerant Therapeutics
-
Cellerant Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 446110 |
Show More
Frequently Asked Questions regarding Cellerant Therapeutics
-
Where are Cellerant Therapeutics's Headquarters?
Cellerant Therapeutics's Headquarters are in 1561 Industrial Rd ,San Carlos,California,United States
-
What is Cellerant Therapeutics's phone number?
Cellerant Therapeutics's phone number is +1 650-232-2122
-
What is Cellerant Therapeutics's official website?
Cellerant Therapeutics's official website is https://www.cellerant.com
-
What is Cellerant Therapeutics's Revenue?
Cellerant Therapeutics's revenue is $10 - 50M
-
What is Cellerant Therapeutics's NAICS code?
Cellerant Therapeutics's NAICS code is 446110
-
How many employees are working in Cellerant Therapeutics
Cellerant Therapeutics has 26 employees
-
What is Cellerant Therapeutics's Industry?
Cellerant Therapeutics is in the industry of Biotechnology
-
Who is Cellerant Therapeutics's Director Research?
Cellerant Therapeutics's Director Research is Deborah Zimmerman

